Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System

NCT01623882 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-11-25

No results posted yet for this study

Summary

The primary purpose of this study is to evaluate the safety and efficacy of the concurrent use of Apligraf® and the SNaP® Wound Care System for the treatment of diabetic and venous stasis lower extremity ulcers.

Conditions

  • Diabetic Foot Ulcer

Sponsors & Collaborators

  • Organogenesis

    collaborator INDUSTRY
  • 3M

    collaborator INDUSTRY
  • KCI USA, Inc

    lead INDUSTRY

Principal Investigators

  • Peter Schubart, MD, PhD · O'Connor Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2014-06-30
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01623882 on ClinicalTrials.gov